1. Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain

   • M. W. Whitehouse
   • K. D. Rainsford

   Editorial Pages: 99 - 102

2. Professor William Watson Buchanan, MB ChB, MD, FRCP (Glas., Edin., C.), FRACP, FRCP (Hon; Ireland), FACR (Hon)

   Obituary Pages: 103 - 119

3. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide

   • K. D. Rainsford

   Review Pages: 120 - 137

4. Therapeutic use of cephazolin to prevent complications of spine surgery

   • R. Walters
   • B. Vernon-Roberts
   • R. Moore

   Research Article Pages: 138 - 143

5. Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A₂ activation interferes with salivary mucin synthesis via platelet activating factor generation

   • B. L. Slomiany
   • A. Slomiany

   Research article 01 August 2006 Pages: 144 - 149

6. Paracetamol [acetaminophen]-induced gastrotoxicity: revealed by induced hyperacidity in combination with acute or chronic inflammation

   • K. D. Rainsford
   • M. W. Whitehouse

   Research Article Pages: 150 - 154

7. Reduced inflammatory potential of peritoneal macrophages recruited in mice pretreated with a glycolipid synthesis inhibitor

   • H. C. Yohe
   • T. J. Kitzmiller
   • J. F. Sinclair

   Short Communication Pages: 155 - 160

8. Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy

   • P. Ghosh
   • S. Shimmon
   • M. W. Whitehouse

   Research Article Pages: 161 - 168

9. Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: a comparative study in rats

   • Mohammad Tariq
   • Meshal Al Moutaery
   • Haseeb Ahmad Khan

   Research Article Pages: 169 - 175